VIVEK ABHYANKAR, MD

Leuprolide acetate (for depot suspension), 7.5 mg

Injection, pegfilgrastim, excludes biosimilar, 0.5 mg

New patient office or other outpatient visit, 60-74 minutes

Administration of chemotherapy into vein, 1 hour or less

New patient office or other outpatient visit, 45-59 minutes

Established patient office or other outpatient visit, 40-54 minutes

Administration of additional new drug or substance into vein, 1 hour or less

Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle

Administration of chemotherapy into vein, each additional hour

Administration of additional new drug or substance into vein using push technique

Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle

Established patient office or other outpatient visit, 30-39 minutes

Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less

Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less

Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion

Infusion into a vein for hydration, 31-60 minutes

Infusion into a vein for therapy, prevention, or diagnosis, each additional hour

Infusion into a vein for hydration, each additional hour

Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg

Established patient office or other outpatient visit, 20-29 minutes

Injection of drug or substance into vein

Injection, pembrolizumab, 1 mg

Irrigation of implanted venous access drug delivery device

Injection, zoledronic acid, 1 mg

Injection of additional new drug or substance into vein

Application of on-body injector for under skin injection

Injection of drug or substance under skin or into muscle

Injection, nivolumab, 1 mg

Injection, ferric derisomaltose, 10 mg

Telephone medical discussion with physician, 5-10 minutes

Injection, denosumab, 1 mg

Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional

Collection of blood sample from central venous tube

Insertion of needle into vein for collection of blood sample

Collection of blood sample from implanted device

Injection, darbepoetin alfa, 1 microgram (non-esrd use)

Injection, carboplatin, 50 mg

Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg

Injection, fluorouracil, 500 mg

Injection, palonosetron hcl, 25 mcg

Infusion, normal saline solution , 1000 cc

Injection, fosaprepitant, 1 mg

Injection, diphenhydramine hcl, up to 50 mg

Unclassified drugs

Injection, iron sucrose, 1 mg

Injection, paclitaxel, 1 mg

Injection, ondansetron hydrochloride, per 1 mg

Injection, potassium chloride, per 2 meq

Injection, dexamethasone sodium phosphate, 1 mg